KE

Kulambi Eswarappa Prakash

Active Director Whole-Time Director DIN 01828357
DIN 01828357 First appointment Sep 2004 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Sep 2004
Shareholding value •••• Premium profile

About Kulambi Eswarappa Prakash

Data last updated:

Kulambi Eswarappa Prakash is a Whole-Time Director at Chethana Pharma Private Limited (since 2019), Director at Chirag Medicare Solutions Private Limited (since 2019) and Director at Chethana Healthcare Solutions Private Limited (since 2019), and holds 1 more current directorship. The companies operate in Pharma and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹513 Cr; the largest is Chethana Pharma Private Limited at ₹232 Cr (FY 2025). Earlier, Kulambi Eswarappa Prakash was a Director at Snehit Healthnet Limited (from 2004).

DIN 01828357
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 17 Sep 2004
Oldest Company Age 22 yrs
Largest company Chethana Pharma Private Limited · ₹232 Cr (FY 2025)
Combined revenue ₹513 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chethana Pharma Private Limited U51909KA2019PTC123150
Whole-Time Director03 Apr 20192019₹232 Cr (FY 2025)Active
Director27 Mar 20192019₹231 Cr (FY 2025)Active
Director27 Mar 20192019₹50.30 Cr (FY 2025)Active
Designated Partner03 Nov 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Snehit Healthnet Limited U51397KA2004PLC034708
Director17 Sep 20042004Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kshema Palliative Care Llp
Snehit Healthnet Limited
Chethana Healthcare Solutions Private Limited
Chirag Medicare Solutions Private Limited
Premium access

Shareholding and investment profile for Kulambi Eswarappa Prakash

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kulambi Eswarappa Prakash

Kulambi Eswarappa Prakash currently holds 4 directorships: Chethana Pharma Private Limited (Whole-Time Director, since 03 Apr 2019, revenue ₹232 Cr (FY 2025)); Chirag Medicare Solutions Private Limited (Director, since 27 Mar 2019, revenue ₹231 Cr (FY 2025)); Chethana Healthcare Solutions Private Limited (Director, since 27 Mar 2019, revenue ₹50.30 Cr (FY 2025)); Kshema Palliative Care Llp (Designated Partner, since 03 Nov 2021).

Kulambi Eswarappa Prakash was first appointed on 17 Sep 2004 as Director at Snehit Healthnet Limited. The most recent appointment on record is 03 Nov 2021 at Kshema Palliative Care Llp.

The 3 current companies of Kulambi Eswarappa Prakash that report revenue have a combined latest revenue of ₹513 Cr: Chethana Pharma Private Limited ₹232 Cr (FY 2025); Chirag Medicare Solutions Private Limited ₹231 Cr (FY 2025); Chethana Healthcare Solutions Private Limited ₹50.30 Cr (FY 2025).

Kulambi Eswarappa Prakash held 1 earlier board appointment: Snehit Healthnet Limited (Director, from 17 Sep 2004).

The current boards of Kulambi Eswarappa Prakash's companies include Praveen (Chethana Pharma Private Limited), Siddharth Upadhyay (Chirag Medicare Solutions Private Limited), Abhitesh Kumar (Chethana Healthcare Solutions Private Limited), Shashwat Nigam (Chethana Healthcare Solutions Private Limited), Kumar Gundagathi Rajasekhara Nayan (Kshema Palliative Care Llp), Vinod Kumar Chamaraj (Kshema Palliative Care Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available